600976 Share Price Performance
CN¥40.36
-12.26 (-23.30%)
Price CN¥40.36
Share PriceCN¥40.36
Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Anemic Earnings Might Be Worse Than You Think
Mar 29
Jianmin Pharmaceutical Group Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
600976 Community Narratives
There are no narratives available yet.
Jianmin Pharmaceutical Group Co.,Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 22, 2025
- Earnings per share (EPS)
- 2.24
- Gross Margin
- 56.91%
- Net Profit Margin
- 10.41%
- Debt/Equity Ratio
- 3.2%
Jianmin Pharmaceutical Group Co.,Ltd. Competitors
Snowflake Analysis
About 600976
- Founded
- 1993
- Employees
- 2345
- CEO
- WebsiteView website
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.4%
- 1 Year: 24.1%
- Year to Date: 26.2%
In the last week, the market is up 1.8% led by Industrials sector. In the last year, the market has climbed 24%. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›